journal of hematology and diabetes (JHD)

Aim and Scope

Journal of Hematology and Diabetes aims to publish the original articles on all aspects of blood disorders that makes advance our understanding of Hematology. 

JHD presents high visibility for author’s work by indexing in various indexing sites and also provides free access to a broad readership with enhanced innovative web technologies, including interactive browsing and efficient data- and text-mining. 

JHD publishes a broad range of hematology research articles including, but not limited to:

Red blood cells
white blood cells
platelets
HemolyticAnemia
Aplastic Anemia
Hematological Oncology
Donor blood/Allo-immunization
Myelodysplastic Syndrome
Sickle Cell Disease
Thalassemia
Hematology
Blood cells
Genetics of Blood Cells
Blood Physiology
Blood Disorders & Diseases
Etiology of Blood
Pathophysiology of Blood Disorders
Blood Malignancies
Blood based Therapeutics or Hemotherapy

Publication of article types:    

Research articles: should report new scientific insights, original technologies or novel methods and must not have been previously published elsewhere, except in a preliminary form.

Review articles: Review articles should provide information about timely syntheses of topical themes that propose new ideas or a provocative new direction for a discipline within the specified topic.

 Short communication:  Should be presented with scientific significant content without exceeding more than 3000 words.

 Case reports: Any clinical case or procedure that illustrates an important best practice clinical guideline and cases which enhance understanding of disease process, its diagnosis, management and clinicopathological correlation.

Editorials: Should be describing the current trends in particular field within aim and scope of the Journal. 

As Journal of Hematology and Diabetes follows the Creative Commons Attribution License and scholars open access publishing policies, readers can freely access the published articles through online and JCRF will be kept up to date with latest advances in the field of neurology. All published articles will be assigned with unique Digital Objective Identifier provided by Cross Ref.


top